Citations

Clear

6055 citation(s) found for "Vu, Peter".

Characterizing the antibody response to amustaline/glutathione pathogen‐reduced red blood cells
Karim, Christopher, Panigrahi, Anil K. , Pearl, Ronald G. , Sodha, Neel R. , Beaver, Thomas M. , Pelletier, J. Peter R. , Nuttall, Gregory A. , Reece, T. Brett , Erickson, Anna , Hedrick, Teresa, Bentow, Stanley, Mufti, Nina, Varrone, Jeanne, Corash, Laurence M , Benjamin, Richard J , Hedrick, Teresa, Liu, Kathy

Mayo Clinic

Transfusion | December 25, 2024 | Volume: 65 | Issue: 2 | Pages: 344-353

10.1111/trf.18117 | PMID 39719927 Get It

AbstractBackgroundThe clinical significance of natural and treatment‐emergent antibodies specific for amustaline/glutathione pathogen‐reduced red blood cells (PRRBCs) is not known.Study Design and MethodsA Phase 3, randomized clinical trial of PRRBCs (ReCePI) compared PRRBCs with conventional RBCs in cardiac or thoracic‐aorta surgery. Subjects transfused during and for 7 days after surgery were screened for PRRBC‐specific antibodies at baseline, 28 and 75 days post‐surgery. Subjects with treatment‐emergent antibodies were assessed for evidence of hemolysis. Cryopreserved subject RBC samples were assayed by flow cytometry for circulating PRRBCs using an acridine‐specific (2S197‐2M1) monoclonal antibody, and for human IgG‐coated RBCs. RBC‐surface acridine density was quantitated using a commercial calibrated phycoerythrin (PE)‐bead panel.ResultsFive of 159 (3.1%) PRRBC and zero of 162 conventional RBC recipients developed treatment‐emergent PRRBC‐specific IgG, low titer antibodies detected 26–80 days post‐surgery after exposure to 1–3 PRRBC units, without clinical evidence of hemolysis. DAT and eluate were weak (w+) positive and PRRBC‐specific in one subject. A monocyte monolayer assay (MMA) was non‐reactive in the three subjects with an interpretable result. Flow cytometry demonstrated circulating PRRBCs in all five subjects expressing surface acridine concentrations at the limit of detection (approximately 150–301 PE molecules/RBC) compared with freshly transfused PRRBCs (approximately 7500 PE molecules/RBC). In some samples, loss of surface acridine expression could not be distinguished from clearance of the PRRBCs.DiscussionTreatment‐emergent PRRBC‐specific antibodies with the characteristics of nonclinically significant antibodies were detected in five subjects transfused with PRRBCs. Flow cytometry demonstrated persistent circulating PRRBCs with minimal surface acridine expression. (www.ClinicalTrials.gov Identifier NCT03459287).
Psychotropic medication usage in sporadic versus genetic behavioral‐variant frontotemporal dementia
Vargas‐González, Juan‐Camilo , Dimal, Nico , Cortez, Kasey, Heuer, Hilary W. , Forsberg, Leah K. , Barmada, Sami J. , Darby, R. Ryan , Domoto‐Reilly, Kimiko , Geschwind, Daniel H. , Ghoshal, Nupur , Graff‐Radford, Neill R., Grant, Ian , Kantarci, Kejal , Mackenzie, Ian R. , Masdeu, Joseph C. , Mendez, Mario F. , Onyike, Chiadi U. , Pascual, Belén , Pressman, Peter , Ramos, Eliana Marisa , Roberson, Erik D. , Rogalskı, Emily , Boxer, Adam L. , Rosen, Howie, Damme, Philip Van , Boeve, Brad F, Roberson, Erik , Kantarci, Kejal , Van Damme, Philip , Pascual, Belen , Domoto-Reilly, Kimiko , Barmada, Sami , Appleby, Brian S. , Bozoki, Andrea C , Clark, David , Cobigo, Yann , Dickerson, Bradford Clark , Galasko, Douglas , Graff‐Radford, Neill R. , Irwin, David J. , Hsiung, Ging‐Yuek Robin , Honig, Lawrence S. , Léger, Gabriel C. , Litvan, Irene , Masdeu, Joseph C , Boeve, Bradley F. , Tartaglia, Maria Carmela

Mayo Clinic

Alzheimer's & Dementia | December 23, 2024 | Volume: 21 | Issue: 2 | Pages: No page available

10.1002/alz.14448 | PMID 39713899 Get It

Abstract INTRODUCTION Psychotropic medication (PM) use in behavioral‐variant frontotemporal dementia (bvFTD) is higher than in other dementias. However, no information exists on whether PM use differs between sporadic and genetic bvFTD. METHODS We analyzed data from sporadic and genetic bvFTD participants with PM prescriptions in the Advancing Research and Treatment in Frontotemporal Lobar Degeneration/Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects study. We estimated ordinal odds ratio (OOR) of having more PM comparing sporadic and genetic bvFTD. Finally, we explored the neuropsychiatric symptom (NPS) combinations using classification and regression trees (CART). RESULTS We included 263 with sporadic and 193 with genetic bvFTD. The OOR for sporadic bvFTD to be on PM was 1.75 (95% confidence interval: 1.21 to 2.53) for the fully adjusted model. CART revealed the most common NPS combination was apathy + personality changes in 18% of participants. DISCUSSION Participants with sporadic bvFTD were twice as likely to be on PM compared to genetic bvFTD. The reason for increased PM usage in sporadic bvFTD participants should be further investigated. Highlights We report on patients with behavioral variant frontotemporal dementia (bvFTD). We evaluated the psychotropic medication (PM) prescription at baseline in the cohort. Patients with sporadic bvFTD had more prescriptions for PM than genetic patients. The frequency of symptoms combination was different in sporadic and genetic bvFTD.
Carotid artery atherosclerosis: mechanisms of instability and clinical implications
Saba, Luca , Cau, Riccardo , Vergallo, Rocco , Kooi, M. Eline , Congiu, Terenzio , Wasserman, Bruce A. , Nardi, Valentina , Kawakami, Rika , Ntaios, George , Kawakami, Rika , Lanzino, Giuseppe , Virmani, Renu , Libby, Peter , Cau, Riccardo , Nardi, Valentina , Kooi, Marianne Eline , Saba, Luca , Staub, Daniel , Faa, Gavino , Benson, John C. , Lanzino, Giuseppe , Virmani, Renu , Libby, Peter

Mayo Clinic

European Heart Journal | December 22, 2024 | Volume: 46 | Issue: 10 | Pages: 904-921

10.1093/eurheartj/ehae933 | PMID 39791527 Get It

Abstract Cardiovascular disease remains a prominent cause of disability and premature death worldwide. Within this spectrum, carotid artery atherosclerosis is a complex and multifaceted condition, and a prominent precursor of acute ischaemic stroke and other cardiovascular events. The intricate interplay among inflammation, oxidative stress, endothelial dysfunction, lipid metabolism, and immune responses participates in the development of lesions, leading to luminal stenosis and potential plaque instability. Even non-stenotic plaques can precipitate a sudden cerebrovascular event, regardless of the degree of luminal encroachment. In this context, carotid imaging modalities have proved their efficacy in providing in vivo characterization of plaque features, contributing substantially to patient risk stratification and clinical management. This review emphasizes the importance of identifying high-risk individuals by use of current imaging modalities, biomarkers, and risk stratification tools. Such approaches inform early intervention and the implementation of personalized therapeutic strategies, ultimately enhancing patient outcomes in the realm of cardiovascular disease management.
Multimorbidity in patients with atrial fibrillation and community controls: A population-based study
Chamberlain, Alanna M. , Alonso, Álvaro , Siontis, Konstantinos C. , Killian, Jill M. , Weston, Susan A., Vaughan, Lisa E. , Manemann, Sheila M., Roger, Véronique L. , Ryu, Euijung , Alonso, Alvaro , Chamberlain, Alanna M , Noseworthy, Peter A. , Gersh, Bernard J.

Mayo Clinic

Journal of Multimorbidity and Comorbidity | December 21, 2024 | Volume: 14 | Issue: No issue available | Pages: No page available

10.1177/26335565241310281 | PMID 39712398 Get It

Background Multimorbidity is common in patients with atrial fibrillation (AF), yet comorbidity patterns are not well documented. Methods The prevalence of 18 chronic conditions (6 cardiometabolic, 7 other somatic, 5 mental health) was obtained in patients with new-onset AF from 2013-2017 from a 27-county region and controls matched 1:1 on age, sex, and county of residence. For AF patients and controls separately, clustering of conditions and co-occurrence beyond chance was estimated (using the asymmetric Somers’ D statistic), overall and for ages <65, 65-74, 75-84, and ≥85 years. Results Among 16,509 patients with AF (median age 76 years, 57% men), few (4%) did not have any of the 18 chronic conditions, whereas nearly one-quarter of controls (23%) did not have any chronic conditions. Clustering of cardiometabolic conditions was common in both AF patients and controls, but clustering of other somatic conditions was more common in AF. Although the prevalence of most condition pairs was higher in AF patients, controls had a larger number of condition pairs occurring together beyond chance. In persons aged <65 years, AF patients more frequently exhibited concordance of condition pairs that included either pairs of somatic conditions or a combination of conditions from different condition groups. In persons aged 65-74 years, AF patients more frequently had pairs of other somatic conditions. Conclusion Patterns of co-existing conditions differed between patients with AF and controls, particularly in younger ages. A better understanding of the clinical consequences of multimorbidity in AF patients, including those diagnosed at younger ages, is needed.
Distinctive clinical features in biopsy-proven nerve large-arteriole vasculitis and microvasculitis
Soontrapa, Pannathat , Pinto, Marcus Vinícius , Shouman, Kamal , Mandrekar, Jay , Engelstad, JaNean , Pinto, Catarina Aragon , Taylor, Sean , Mauermann, Michelle L. , Berini, Sarah E. , Bosch, E. Peter, Rubin, Devon I., Weyand, Cornelia M. , Dyck, Peter James , Pinto, Marcus V , Mauermann, Michelle L , Soontrapa, Pannathat , Koster, Matthew J. , Warrington, Kenneth J. , Klein, Christopher J.

Mayo Clinic

Brain | December 20, 2024 | Volume: 148 | Issue: 3 | Pages: 1031-1042

10.1093/brain/awae406 | PMID 39715342 Get It

Abstract Vasculitic neuropathy is caused by inflammatory destruction of nerve blood vessels resulting in nerve ischaemia. Nerve vasculitis can be divided into two categories based on vessel size: large-arteriole vasculitis (≥75 µm) and microvasculitis (&lt;75 µm). Herein, we characterize the clinical features of nerve large-arteriole vasculitis in comparison to nerve microvasculitis. This is a retrospective cohort study of patients evaluated and biopsied at Mayo sites between 2001 and 2020. We collected clinical and histopathological data from patients whose nerve biopsies were either diagnostic or highly suggestive of nerve vasculitis. Two hundred and seventy-eight cases were identified: 125 cases of large-arteriole vasculitis and 153 cases of microvasculitis. Nerve large-arteriole vasculitis presented with a more acute (50.4% versus 26.8%) versus chronic onset (33.6% versus 57.5%) than nerve microvasculitis (P = 0.0001). Nerve microvasculitis had longer mean time to diagnosis (10.5 versus 4.3 months; P &lt; 0.0001) and longer time to plateau (8.9 versus 3.5 months; P &lt; 0.0001). Nerve large-arteriole vasculitis typically presented as distal asymmetric polyneuropathy (48.0%), whereas nerve microvasculitis typically presented as radiculoplexus neuropathy/polyradiculoneuropathy (more proximal involvement of shoulder and thigh) (43.8%) (P &lt; 0.0001). Systemic autoimmune disease was more common in nerve large-arteriole vasculitis (70.4% versus 22.9%, odds ratio, 8.0; 95% confidence interval, 4.7–13.7; P &lt; 0.0001). Nerve microvasculitis was significantly related to non-systemic vasculitis (71% versus 23%, odds ratio, 7.9; 95% confidence interval, 4.6–13.6; P &lt; 0.0001). Nerve microvasculitis had more autonomic involvement (24.2% versus 7.2%, odds ratio, 4.1; 95% confidence interval, 1.9–8.9; P = 0.0002). Nerve large-arteriole vasculitis and nerve microvasculitis have different but overlapping clinical features. Nerve large-arteriole vasculitis usually presents with acute onset, distal asymmetric polyneuropathy, associated with other autoimmune diseases and systemic involvement. In contrast, nerve microvasculitis usually presents with a subacute/chronic onset, as radiculoplexus neuropathy/polyradiculopathy (distal and proximal pattern) with autonomic involvement, and is more often a form of non-systemic vasculitis.
Investigating the added value of incorporating mammographic density to an integrated breast cancer risk model with questionnaire-based risk factors and polygenic risk score
Mulder, Charlotta , Yang, Xin , Jee, Yon Ho , Gao, Chi , Cao, Yu , Hurson, Amber N. , Vachon, Celine M. , Hall, Per, Antoniou, Antonis C., Kraft, Peter, Choudhury, Parichoy Pal , Eriksson, Mikael , Vachon, Celine M. , Hall, Per N , Antoniou, Antonis C. , Gierach, Gretchen L. , García‐Closas, Montserrat

Mayo Clinic

No container title available | December 19, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-5445786/v1 | PMID 39764121 Get It

Abstract Introduction Incorporation of mammographic density to breast cancer risk models could improve risk stratification to tailor screening and prevention strategies according to risk. Robust evaluation of the value of adding mammographic density to models with comprehensive information on questionnaire-based risk factors and polygenic risk score is needed to determine its effectiveness in improving risk stratification of such models. Methods We used the Individualized Coherent Absolute Risk Estimator (iCARE) tool for risk model building and validation to incorporate density to a previously validated literature-based model with questionnaire-based risk factors and a 313-variant polygenic risk score (PRS). The model was evaluated for calibration and discrimination in three prospective cohorts of European-ancestry women (1,468 cases, 19,104 controls): US-based Nurses’ Health Study (NHS I and II) and Mayo Mammography Health Study (MMHS); and Sweden-based Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA) study. Analyses were done separately for women younger (NHS II, KARMA) and older than 50 years (NHS I, MMHS, KARMA). Improvements in terms of risk stratification and reclassification proportions were assessed among European-ancestry women aged 50–70 years in US and Sweden. Results For women younger and older than 50 years, the model with questionnaire-based risk factors, PRS and density was generally well calibrated across risk with some evidence of miscalibration at the extremes of the risk distribution. Incorporation of density led to modest improvements risk discrimination beyond the model with questionnaire-based risk factors and PRS: the area under the curve (AUC) among younger women was 67.0% (95% CI: 63.5–70.6%) vs. 65.6% (95% CI: 61.9–69.3%) for models with and without density; and 66.1% (95% CI 64.4–67.8%) vs. 65.5% (95% CI: 63.8–67.2%) among older women. The model with density identified 18.4% of US women 50–70 years old ≥ 3% 5-year predicted risk (threshold used for recommending risk-reducing medication in the US), with 42.4% of future cases expected to occur in this group. At this threshold, 7.9% of US women were reclassified by adding density to the model, resulting in the identification of 2.8% of additional future cases. The model with density identified 10.3% of Swedish women ≥ 3% 5-year predicted risk, with 29.4% of future cases expected to occur in this group. At this threshold, 5.3% of women were reclassified with the addition of density, leading to the identification of an additional 4.4% of future cases. Conclusion Integrating density with questionnaire-based risk factors and PRS could potentially identify more women of European-ancestry with elevated risk of breast cancer in the United States and Sweden. Further investigations of the integrated model in non-European ancestry populations are needed prior to considering clinical applications.
Knowledge-Informed Machine Learning for Cancer Diagnosis and Prognosis: A Review
Mao, Lingchao , Wang, Hairong, Hu, Leland , Tran, Nhan L. , Canoll, Peter , Swanson, Kristin R. , Li, Jing , Wang, Hairong , Hu, Leland S , Mao, Lingchao , Swanson, Kristin R , Tran, Nhan L , Li, Jing

Mayo Clinic

IEEE Transactions on Automation Science and Engineering | December 18, 2024 | Volume: 22 | Issue: No issue available | Pages: 10008-10028

10.1109/tase.2024.3515839 | PMID 40893871 Get It

Smart Driving Technology for Non-Invasive Detection of Age-Related Cognitive Decline
Serhan, Peter , Victor, Shaun , Pérez, Óscar Osorio , Karam, Kevin Abi , Elghoul, Anthony Ziad, Ransdell, Madison , Al-Hindawi, Firas , Geda, Yonas E. , Chahal, Geetika, Eagan, Danielle E., Tsow, Francis , Forzani, Erica , Abi Karam, Kevin, Elghoul, Anthony, Geda, Yonas E , Perez, Oscar Osorio, Wu, Teresa

Mayo Clinic

Sensors | December 18, 2024 | Volume: 24 | Issue: 24 | Pages: 8062

10.3390/s24248062 | PMID 39771798 Get It

Alzheimer’s disease (AD) and Alzheimer’s Related Dementias (ADRD) are projected to affect 50 million people globally in the coming decades. Clinical research suggests that Mild Cognitive Impairment (MCI), a precursor to dementia, offers a critical window of opportunity for lifestyle interventions to delay or prevent the progression of AD/ADRD. Previous research indicates that lifestyle changes, including increased physical exercise, reduced caloric intake, and mentally stimulating activities, can reduce the risk of MCI. Early detection of MCI is challenging due to subtle and often unnoticed cognitive decline and is traditionally monitored through infrequent clinical tests. In this research, the Smart Driving System, a novel, unobtrusive, and economical technology to detect early stages of neurodegenerative diseases, is presented. The system comprises a multi-modal biosensing array (MMS) and AI algorithms, including driving performance and driver’s biometrics, offering insights into a driver’s cognitive function. This publication is the first work reported towards the ultimate goal of developing the Smart Driving Device and App, integrating it into vehicles, and validating its effectiveness in detecting MCI through comprehensive pilot studies.
Delphi-Based Global Consensus on Adopting Endothelial Keratoplasty: An Endothelial Keratoplasty Learners Group Initiative
Bhogal, Maninder, Gupta, Nidhi , Giobellina, Ticiano, Kobayashi, Akira , Males, John , Mehta, Jodhbir S., Romano, Vito , Allan, Bruce, Fogla, Rajesh , Gorovoy, Mark , McKee, Yuri, Koo, Ellen H. , Kocaba, Viridiana , Mejia, Luis Fernando, Moriyama, Aline Silveira , Pereira, Nicolas Cesário , Price, Francis W. , Rapuano, Christopher J. , Rostov, Audrey Talley, Slomovic, Allan R. , Terry, Mark A., Veldman, Peter B., Mehta, Jodhbir Singh , Busin, Massimo , Cursiefen, Claus , Patel, Sanjay V. , Saad, Alain , Sharma, Namrata , Sutton, Gerard L , Tu, Elmer Yuchen , Pineda, Roberto , Vaddavalli, Pravin Krishna

Mayo Clinic

Cornea | December 17, 2024 | Volume: 44 | Issue: 8 | Pages: 1010-1021

10.1097/ico.0000000000003758 | PMID 39688243 Get It

Purpose: To identify areas of consensus among experts on the performance of endothelial keratoplasty by using a modified Delphi approach, to help create a framework for novice surgeons to adopt these procedures. Methods: Thirty-one international experts in endothelial keratoplasty participated. Two rounds of electronic survey were followed by a hybrid, virtual meeting. Consensus was set at 75%, and results with agreement between 70% and 75% were deemed as achieving near consensus. Results: A consensus was reached for 98 statements covering the preoperative, intraoperative, and postoperative aspects of Descemet membrane endothelial keratoplasty (DMEK) and Descemet stripping endothelial keratoplasty/Descemet stripping automated endothelial keratoplasty. Four statements achieved near consensus, and consensus could not be achieved for 11 statements. For DMEK, the panel supported a peel technique to prepare tissue for endothelium out DMEK, implanted via an injector and supported by a near full air/gas fill as a baseline procedure onto which more advanced techniques can be built. DMEK tissue should be marked to ensure correct orientation. An inferior peripheral iridotomy should be used to prevent pupil block when a near full air/gas fill in used in endothelial keratoplasty (EK). Descemet stripping automated endothelial keratoplasty was considered preferable to Descemet stripping endothelial keratoplasty where access to microkeratome preparation was available. Conclusions: The Delphi process allowed areas of consensus on the performance of EK to be established by a group of international experts. The statements generated are a helpful framework for novice surgeons learning EK. Further research is needed to help determine what specific tomographic features indicate EK, when guttae are considered visually significant and how to approach combined aphakia and endothelial dysfunction.
Estimating surgical blood loss: A review of current strategies in various clinical settings
Stoker, Alexander, Binder, William J. , Frasco, Peter E. , Morozowich, Steven T., Bettini, Layne M, Murray, Andrew W. , Fah, Megan K, Gorlin, Andrew , Stoker, Alex D , Binder, Will J , Gorlin, Andrew W, Bettini, Layne M., Fah, Megan K.

Mayo Clinic

SAGE Open Medicine | December 17, 2024 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/20503121241308302 | PMID 39691865 Get It

The estimation of surgical blood loss is routinely performed during and after surgical procedures and has morbidity and mortality implications related to the risk of under- and over-resuscitation. The strategies for estimating surgical blood loss include visual estimation, the gravimetric method, the colorimetric method, formula-based methods, and other techniques (e.g., cell salvage). Currently, visual estimation continues to be the most widely used technique. In addition, unique considerations exist when these techniques are applied to various clinical settings such as massive transfusion, cardiac surgery, and obstetrics. Ultimately, when using estimated surgical blood loss to guide perioperative fluid management and transfusion thresholds, it is also important to mitigate the risks associated with resuscitation by targeting a goal-directed fluid therapy approach by utilizing markers of fluid-responsiveness to optimize stroke volume (cardiac output) and delivery of oxygen.